Cargando…
Absorption and distribution of etoricoxib in plasma, CSF, and wound tissue in patients following hip surgery—a pilot study
The perioperative administration of selective cyclooxygenase-2 (COX-2)-inhibitors to avoid postoperative pain is an attractive option: they show favorable gastro-intestinal tolerability, lack inhibition of blood coagulation, and carry a low risk of asthmatic attacks. The purpose of this study was to...
Autores principales: | Renner, Bertold, Zacher, Josef, Buvanendran, Asokumar, Walter, Gerrit, Strauss, Jochen, Brune, Kay |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807935/ https://www.ncbi.nlm.nih.gov/pubmed/20052461 http://dx.doi.org/10.1007/s00210-009-0482-0 |
Ejemplares similares
-
Preoperative administration of etoricoxib in patients undergoing hip replacement causes inhibition of inflammatory mediators and pain relief
por: Renner, B, et al.
Publicado: (2012) -
Complex Regional Pain Syndrome: A Comprehensive Qualitative Research Study on Unmet Needs in the “Patient Journey”
por: Raja, Srinivasa N, et al.
Publicado: (2021) -
Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study
por: Küster, Michael, et al.
Publicado: (2013) -
Etoricoxib for arthritis and pain management
por: Brooks, Peter, et al.
Publicado: (2006) -
The cardiovascular risks of etoricoxib (Arcoxia)
por: Sasich, Larry D., et al.
Publicado: (2008)